Heba T Abdel-Mohsen

13PUBLICATIONS
12CO-AUTHORS
Biomolecular modelling and designPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 12, 2026
Dual targeting of VEGFR-2 and FAK kinases by novel benzimidazole-oxadiazole hybrids: a potential approach in cancer therapy.

|Oct 21, 2025
Recent advances in the design, development and therapeutic applications of PPARγ agonists.

Iman A Y Ghannam, Heba T Abdel-Mohsen, Islam H Ali

|Sep 13, 2024
Benzimidazole-dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions.

Heba T Abdel-Mohsen, Amira M Nageeb

|Aug 24, 2024
Diphenyl urea-benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents.

Heba T Abdel-Mohsen, Amira M Nageeb, Iman A Y Ghannam

|Jul 23, 2024
Benzimidazole-oxindole hybrids: A novel class of selective dual CDK2 and GSK-3β inhibitors of potent anticancer activity.

Heba T Abdel-Mohsen, Yasmin M Syam, Mahmoud S Abd El-Ghany

|Jul 12, 2024
Quinazoline-oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies.

Yasmin M Syam, Somaia S Abd El-Karim, Heba T Abdel-Mohsen

Pageof 3

Frequent Collaborators

3 joint publications

Claudiu T Supuran

2 joint publications

Hoda I El Diwani

2 joint publications

Iman A Y Ghannam

1 joint publications

Adel S Girgis